LncRNA Gas5, a Target of the Nonsense-Mediated Decay Pathway in the Brain, Regulates Neuroinflammation and Neurodegenerative Disease Pathways in a Tauopathy Mouse Model
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177675 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Meredith Krause-Hauch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, James A. Haley Veterans' Hospital, Tampa, FL 33612, USA. Hauptthemen laut MEDLINE: Tauopathies, Nonsense Mediated mRNA Decay, Brain, RNA, Long Noncoding. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIH HHS, United States Department of Veterans Affairs.
Abstract (Originalsprache)
Dysregulation of target genes of nonsense-mediated decay (NMD) in the brain remains sparsely known in tauopathies. PS19 transgenic mice expressing human mutant P301S tau were evaluated for levels of lncRNA Gas5, a target of NMD. The results show Gas5 decreased in the brains of PS19 mice as they aged. We evaluated the consequences of blocking the NMD-mediated turnover of Gas5 using a small molecule administered intranasally to PS19 mice. The results show NPC86 disassociated Upf1 and Gas5, thereby hindering NMD. NPC86 treatment increased Gas5 levels in the cortex of male PS19 mice concurrent with a highly significant decrease in pTau S214 and neuroinflammatory genes while increasing insulin signaling. Consequently, digital spatial profiling identified Gas5-regulated genes and pathways. NPC86 treatment enhanced neuronal homeostasis, synaptic vesicle transport and mitochondrial function and downregulated neuroinflammatory pathways. The nodal genes in Parkinson’s signaling pathway, the multiple sclerosis signaling pathway, the Gα(s) signaling pathway, the neuroinflammation signaling pathway, and the interferon gamma signaling pathway were decreased in response to NPC86. The study demonstrates the potential of selectively stabilizing NMD-target lncRNA Gas5 levels to alleviate early neurodegenerative pathology in tauopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Service, James A. Haley Veterans' Hospital, Tampa, FL 33612, USA.
- Byrd Alzheimer's Center and Research Institute, Tampa, FL 33613, USA.
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
- Department of Chemistry, University of South Florida, Tampa, FL 33612, USA.
ORCID-Profile: Ashutosh Dharap, Niketa A Patel
Förderung
- BLRD VA
- NIH HHS
- United States Department of Veterans Affairs
- NIA NIH HHS
- U.S. Department of Veterans Affairs
- NIH NINDS
- NIH NIA
- NIH
Zitieren
APA
Krause-Hauch, M., Wang, B., Patel, R. S., Verdina, L., Hedrick, A., Blair, L. J., Dharap, A., Cai, J., & Patel, N. A. (2026). LncRNA Gas5, a Target of the Nonsense-Mediated Decay Pathway in the Brain, Regulates Neuroinflammation and Neurodegenerative Disease Pathways in a Tauopathy Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177675
Vancouver
Krause-Hauch M, Wang B, Patel RS, Verdina L, Hedrick A, Blair LJ, et al. LncRNA Gas5, a Target of the Nonsense-Mediated Decay Pathway in the Brain, Regulates Neuroinflammation and Neurodegenerative Disease Pathways in a Tauopathy Mouse Model. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177675
BibTeX
@article{KrauseHauch2026,
author = {Krause-Hauch, Meredith and Wang, Bangmei and Patel, Rekha S and Verdina, Laura and Hedrick, Ashley and Blair, Laura J and Dharap, Ashutosh and Cai, Jianfeng and Patel, Niketa A},
title = {LncRNA Gas5, a Target of the Nonsense-Mediated Decay Pathway in the Brain, Regulates Neuroinflammation and Neurodegenerative Disease Pathways in a Tauopathy Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177675}
}
EUVIMED